160 related articles for article (PubMed ID: 6788061)
1. Hormone and drug effects on growth of DMBA mammary tumours and plasma prolactin levels in adreno-ovariectomized rats.
Minasian-Batmanian LC; Jabara AG
Br J Cancer; 1981 Jun; 43(6):832-41. PubMed ID: 6788061
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
3. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of carcinogen-induced mammary tumor growth in rats by adrenalectomy.
Chen HJ; Bradley CJ; Meites J
Cancer Res; 1976 Apr; 36(4):1414-7. PubMed ID: 816463
[TBL] [Abstract][Full Text] [Related]
5. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
Boylan ES; Fowler EH; Wittliff JL
Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
[TBL] [Abstract][Full Text] [Related]
6. Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors.
Lawson DM; Sensui N; Haisenleder DH; Kaufman PN; Gala RR
Breast Cancer Res Treat; 1984; 4(2):129-36. PubMed ID: 6430370
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
Gandilhon P; Melancon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
[TBL] [Abstract][Full Text] [Related]
8. [The behavior of 7, 12-dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in rats during pregnancy and lactation and hormone levels in the pituitary and plasma (author's transl)].
Sakamoto S; Imamura Y; Sassa S; Okamoto R
Nihon Naibunpi Gakkai Zasshi; 1979 Mar; 55(3):210-8. PubMed ID: 108141
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
Labrie F; Kelly PA; Asselin J; Raynaud JP
Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798
[TBL] [Abstract][Full Text] [Related]
10. Effects of dehydroepiandrosterone and other sex steroid hormones on mammary carcinogenesis by direct injection of 7,12-dimethylbenz(a) anthracene (DMBA) in hyperprolactinemic female rats.
Kohama T; Terada S; Suzuki N; Inoue M
Breast Cancer Res Treat; 1997 Apr; 43(2):105-15. PubMed ID: 9131265
[TBL] [Abstract][Full Text] [Related]
11. High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
Di Carlo F; Muccioli G; Bellussi G; Conti G; Racca S
Int J Cancer; 1988 May; 41(5):767-70. PubMed ID: 2966772
[TBL] [Abstract][Full Text] [Related]
12. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
13. Plasma hormone levels and the incidence of carcinogen-induced mammary tumours in two strains of rat.
Hawkins RA; Drewitt D; Freedman B; Killin E; Jenner DA; Cameron EH
Br J Cancer; 1976 Nov; 34(5):546-9. PubMed ID: 826265
[TBL] [Abstract][Full Text] [Related]
14. Mammary tumorigenesis in chemical carcinogen-treated mice. VII. Prolactin and progesterone levels in BALB/c mice.
Medina D; O'Bryan SB; Warner MR; Sinha YN; VanderLaan WP; McCormack S; Hahn P
J Natl Cancer Inst; 1977 Jul; 59(1):213-9. PubMed ID: 406413
[TBL] [Abstract][Full Text] [Related]
15. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
16. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Waseda N; Kato Y; Matsushita N; Imura H
Endocrinol Jpn; 1983 Aug; 30(4):529-35. PubMed ID: 6323151
[TBL] [Abstract][Full Text] [Related]
17. Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats.
Yoshida H; Fukunishi R; Kato Y; Matsumoto K
J Natl Cancer Inst; 1980 Oct; 65(4):823-8. PubMed ID: 6775121
[TBL] [Abstract][Full Text] [Related]
18. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments.
Thordarson G; Semaan S; Low C; Ochoa D; Leong H; Rajkumar L; Guzman RC; Nandi S; Talamantes F
Breast Cancer Res Treat; 2004 Oct; 87(3):277-90. PubMed ID: 15528971
[TBL] [Abstract][Full Text] [Related]
19. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
Koseki Y; Cole D; Matsuzawa A; Costlow ME
Jpn J Cancer Res; 1987 Oct; 78(10):1105-11. PubMed ID: 3119544
[TBL] [Abstract][Full Text] [Related]
20. Effect of prolactin and estradiol on cell proliferation in the uterus and the MXT mouse mammary neoplasm.
Kiss R; de Launoit Y; L'Hermite-Balériaux M; L'Hermite M; Paridaens RJ; Danguy AJ; Pasteels JL
J Natl Cancer Inst; 1987 May; 78(5):993-8. PubMed ID: 3472006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
